Science Explorer Back to mapMap
Discussion
Topic · Pulmonary and Respiratory Medicine

Renal and Vascular Pathologies

Renal and Vascular Pathologies is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 35k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and treatment of renal artery stenosis, including topics such as fibromuscular dysplasia, renovascular hypertension, renal function, stent placement, doppler ultrasonography, atherosclerotic renovascular disease, renal transplantation, oxidative stress, and angioplasty.

  • Renal Artery Stenosis
  • Fibromuscular Dysplasia
  • Renovascular Hypertension
  • Renal Function
  • Stent Placement
  • Doppler Ultrasonography
  • Atherosclerotic Renovascular Disease
  • Renal Transplantation
  • Oxidative Stress
  • Angioplasty
Research works
35k
fractional, since 1950
In the world top 10%
3.6k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+3%
the tick is no change
Largest producer
United States
37% of the 10 largest, 2022-now
Renal and Vascular Pathologies

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Renal and Vascular Pathologies research?

By volume, the United States and China publish the most (1.4k and 594 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.4k works
  2. 2 China 594 works
  3. 3 India 392 works
  4. 4 Japan 305 works
  5. 5 United Kingdom 233 works
  6. 6 Italy 213 works
  7. 7 Germany 187 works
  8. 8 France 159 works
  9. 9 Türkiye 155 works
  10. 10 South Korea 145 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 36.7%China: 15.8%India: 10.4%Japan: 8.1%6 others listed: 29.0%37%largest
United States1,379 · 36.7%China594 · 15.8%India392 · 10.4%Japan305 · 8.1%6 others listed1,092 · 29.0%

Shares of the rows listed above, not of the whole node.

Which institutions lead Renal and Vascular Pathologies research?

By volume in 2022-now, Mayo Clinic publishes the most Renal and Vascular Pathologies research, followed by Harvard University and All India Institute of Medical Sciences.

By volume, 2022-now

  1. 1 Mayo ClinicUnited States 51 works
  2. 2 Harvard UniversityUnited States 44 works
  3. 3 All India Institute of Medical SciencesIndia 32 works
  4. 4 Capital Medical UniversityChina 30 works
  5. 5 Johns Hopkins UniversityUnited States 26 works
  6. 6 Cleveland ClinicUnited States 25 works
  7. 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 24 works
  8. 8 University of TorontoCanada 24 works
  9. 9 Sun Yat-sen UniversityChina 23 works
  10. 10 InsermFrance 21 works

Who are the leading researchers in Renal and Vascular Pathologies?

The most-cited researchers publishing on Renal and Vascular Pathologies include John J.V. McMurray, Hermann Brenner and Stephan Windecker.

  1. 1 John J.V. McMurray United Kingdom 349k citations
  2. 2 Hermann Brenner Germany 343k citations
  3. 3 Stephan Windecker Switzerland 338k citations
  4. 4 Giuseppe Remuzzi Italy 328k citations
  5. 5 Graeme J. Hankey Australia 316k citations
  6. 6 Gordon Henry Guyatt Canada 315k citations
  7. 7 Gregory Y.H. Lip United Kingdom 311k citations
  8. 8 Salim Yusuf Canada 294k citations
  9. 9 Luigi Ferrucci United States 281k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Renal and Vascular Pathologies?

The most cited paper in Renal and Vascular Pathologies is "Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes" (Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al., 2001), with 6,043 citations. Next come "Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)" (3,992) and "Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis" (3,625).

Most cited papers
#PaperReleasedCitations
1 Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine Open access 20 Sep 2001 6,043
2 Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Andrew S. Levey, Kai‐Uwe Eckardt, Yusuke Tsukamoto et al. · Kidney International Open access 6 May 2005 3,992
3 Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis Henry J.M. Barnett, D. Wayne Taylor, Michael Eliasziw et al. · New England Journal of Medicine Open access 12 Nov 1998 3,625
4 Birth Prevalence of Congenital Heart Disease Worldwide Denise van der Linde, Elisabeth E.M. Konings, M. A. Slager et al. · Journal of the American College of Cardiology Open access Nov 2011 3,541
5 The Banff 97 working classification of renal allograft pathology Lorraine C. Racusen et al. · Kidney International Open access Feb 1999 3,059
All 100 most cited papers, with filters and sorting

Where is Renal and Vascular Pathologies research done?

The largest centres of Renal and Vascular Pathologies research in 2022-now are Beijing (China), Seoul (South Korea), London (United Kingdom) and New York (United States).

Largest cities, 2022-now

  1. 1 BeijingChina 113 works
  2. 2 SeoulSouth Korea 83 works
  3. 3 LondonUnited Kingdom 72 works
  4. 4 New YorkUnited States 69 works
  5. 5 TokyoJapan 68 works
  6. 6 IstanbulTürkiye 55 works
  7. 7 ParisFrance 53 works
  8. 8 MoscowRussia 49 works
  9. 9 BostonUnited States 48 works
  10. 10 GuangzhouChina 47 works
See Renal and Vascular Pathologies on the map

Where is the best place to study Renal and Vascular Pathologies?

Among universities, judged by research, Harvard University, New York University and University of Toronto score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.96%fractional works in this field (log) →share of work in the world top 10% →University of FlorenceNew York UniversityHarvard UniversityUniversity of Toronto
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 76.016.3%2.8×44 +9.7%
2New York UniversityUnited States 67.924.6%3.5×19 +145.3%
3University of TorontoCanada 61.514.8%2.4×24 -1.4%
4University of FlorenceItaly 61.035.4%3.4×10 +7.4%
5Columbia UniversityUnited States 59.019.7%2.9×16 +31.8%
6Sun Yat-sen UniversityChina 57.921.4%2.3×23 +11.8%
7Johns Hopkins UniversityUnited States 55.913.4%3.4×26 -20.6%
8University of PennsylvaniaUnited States 55.412.6%3.8×20 +38.5%
9University of British ColumbiaCanada 54.721.2%1.9×11 +63.8%
10University of GroningenNetherlands 54.420.2%3.7×12 -8.5%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Renal and Vascular Pathologies, country by country

Is Renal and Vascular Pathologies research growing?

Output in 2022-2025 was 3% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Renal and Vascular Pathologies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Renal and Vascular Pathologies as a percentage of every work published that year, 0.025% in 2024.

still counting0.020%0.040%0.060%Renal and Vascular Pathologies0.024% in 202519801990200020102020

Fractional works of Renal and Vascular Pathologies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Renal and Vascular Pathologies10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Renal and Vascular Pathologies. Posts are plain text and can be reported.